Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001161697-23-000623)

Filing Details

Accession Number:: 0001161697-23-000623
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-14 17:00:09
Reporting Period:: 2023-12-12

Accepted Time:: 2023-12-14 17:00:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369568	Catalyst Pharmaceuticals Inc.	CPRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292636	S David Tierney	355 Alhambra Circle, Suite 801 Coral Gables FL 33134		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2023-12-12	50,000	$1.13	383,541	No	4	M	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2023-12-12	50,000	$13.33	333,541	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase common stock	Acquisiton	2023-12-12	50,000	$0.00	50,000	$1.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
244,264		2024-01-03	No	4	M	Direct

Footnotes

Shares were sold on the open market for personal reasons, and to fund the exercise price for stock options expiring on January 3, 2024, and not as a result of any disagreement with the Company.
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.30 to $13.36 per share.
Options vested in three annual tranches beginning on January 3, 2018.